At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with ...

NAFRA's renewed engagement places SMX on the radar of the operators who feel the impact most. NEW YORK, NY / ACCESS Newswire ...

Exhibitors will present a healthy mix of proven and new products at the Lamma show in January. We asked them to nominate one ...

Environmental exposures are emerging as major contributors to autoimmune risk: Studies link air pollution, PFAS, and ...

Enterprise Products Partners (EPD) stands out for steady growth, strong yields, and undervalued potential. Read here for more ...

Plastics are a six-hundred-billion-dollar global industry operating on unreliable data. More than four hundred million metric ...

IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 3:30 PM ESTCompany ParticipantsArun Jeldi ...

The ALSTARS Trial is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of COYA 302 in patients with amyotrophic lateral sclerosis (ALS) ...

This study presents a valuable advance in reconstructing naturalistic speech from intracranial ECoG data using a dual-pathway model. The evidence supporting the claims of the authors is solid, ...

Q2 2026 Earnings Call Transcript December 15, 2025Ocean Power Technologies, Inc. misses on earnings expectations.

NEW YORK, NY / ACCESS Newswire / December 3, 2025 / For decades, every industry has been held back by the same flaw. They rely on materials they cannot truly verify. Plastics with unverifiable ...

Saagar Govil, Cemtrex Chairman and CEO, emphasized this long-term positioning, noting that Invocon's decades of flight-proven systems are "extremely difficult to replicate" and aligned with key ...